A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis; the Grafiti trial

[1]  W. V. van IJcken,et al.  Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A Tumors , 2020, Frontiers in Oncology.

[2]  C. Raut,et al.  Desmoid tumors: To treat or not to treat, That is the question , 2020, Cancer.

[3]  S. Sleijfer,et al.  Active surveillance in desmoid-type fibromatosis: A systematic literature review. , 2020, European journal of cancer.

[4]  L. Qin,et al.  Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. , 2020, Annals of surgery.

[5]  H. Cho,et al.  Factors Associated with Disease Stabilization of Desmoid-Type Fibromatosis , 2020, Clinics in orthopedic surgery.

[6]  Robin L. Jones,et al.  The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. , 2020, European journal of cancer.

[7]  Robin L. Jones,et al.  Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance , 2019, Annals of Surgical Oncology.

[8]  E. Kurien,et al.  Surgical excision versus observation as initial management of desmoid tumors: A population based study. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  P. Pickhardt,et al.  Volumetric analysis at abdominal CT: oncologic and non-oncologic applications. , 2019, The British journal of radiology.

[10]  Narasimhan P. Agaram,et al.  Sorafenib for Advanced and Refractory Desmoid Tumors , 2018, The New England journal of medicine.

[11]  F. van Coevorden,et al.  Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands , 2018, Sarcoma.

[12]  J. Blay,et al.  Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. , 2017, European journal of cancer.

[13]  F. van Coevorden,et al.  Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention , 2016, BMC Cancer.

[14]  A. Shinagare,et al.  Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  M. Meyerson,et al.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis , 2015, Genes, chromosomes & cancer.

[16]  M. D. den Bakker,et al.  Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study , 2015, Annals of surgical oncology.

[17]  C. Verhoef,et al.  Prognostic Value of CTNNB1 Gene Mutation in Primary Sporadic Aggressive Fibromatosis , 2015, Annals of Surgical Oncology.

[18]  D. Biau,et al.  Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. , 2014, The Journal of bone and joint surgery. American volume.

[19]  S. Bonvalot,et al.  Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought , 2013, Annals of Surgical Oncology.

[20]  T. van Dalen,et al.  Local recurrence after surgery for primary extra‐abdominal desmoid‐type fibromatosis , 2013, The British journal of surgery.

[21]  M. Gonen,et al.  A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis , 2013, Annals of surgery.

[22]  E. Walker,et al.  Magnetic resonance imaging of malignant soft tissue neoplasms in the adult. , 2011, Radiologic clinics of North America.

[23]  O. Dekkers,et al.  A nation‐wide study comparing sporadic and familial adenomatous polyposis‐related desmoid‐type fibromatoses , 2011, International journal of cancer.

[24]  L. Mariani,et al.  Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment , 2009, Annals of Surgical Oncology.

[25]  緑佐 中村,et al.  NSAIDs (Non-steroidal anti-inflammatory drugs) とメトホルミン内服により急性腎不全, 低血糖および乳酸アシドーシスを発症した先天性副腎過形成を有した2型糖尿病患者の1例 , 2009 .

[26]  J. Blay,et al.  Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  D. Leung,et al.  The enigma of desmoid tumors. , 1999, Annals of surgery.

[28]  J. Huisman.  The Netherlands , 1996, The Lancet.

[29]  J. Reitamo,et al.  The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. , 1982, American journal of clinical pathology.

[30]  E. Saxén,et al.  The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. , 1982, American journal of clinical pathology.

[31]  S. Bonvalot,et al.  Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. , 2015, European journal of cancer.

[32]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.